Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.
Risk & Volatility
Defiance Daily Target 2X Long LMND ETF has a beta of -7.64, meaning that its stock price is 864% less volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.33, meaning that its stock price is 133% more volatile than the S&P 500.
Earnings and Valuation
This table compares Defiance Daily Target 2X Long LMND ETF and INVO Fertility”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Defiance Daily Target 2X Long LMND ETF | $437.66 million | 0.01 | $15.17 million | $0.51 | 24.08 |
| INVO Fertility | $6.84 million | 0.32 | -$25.13 million | ($3,151.46) | 0.00 |
Defiance Daily Target 2X Long LMND ETF has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Defiance Daily Target 2X Long LMND ETF, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Defiance Daily Target 2X Long LMND ETF and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Defiance Daily Target 2X Long LMND ETF | 5.39% | 4.66% | 2.91% |
| INVO Fertility | -183.75% | -420.62% | -45.21% |
Analyst Ratings
This is a summary of recent ratings and recommmendations for Defiance Daily Target 2X Long LMND ETF and INVO Fertility, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Defiance Daily Target 2X Long LMND ETF | 0 | 0 | 0 | 0 | 0.00 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 1,512.90%. Given INVO Fertility’s stronger consensus rating and higher possible upside, analysts clearly believe INVO Fertility is more favorable than Defiance Daily Target 2X Long LMND ETF.
Insider & Institutional Ownership
87.8% of Defiance Daily Target 2X Long LMND ETF shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 6.6% of Defiance Daily Target 2X Long LMND ETF shares are owned by insiders. Comparatively, 0.7% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Defiance Daily Target 2X Long LMND ETF beats INVO Fertility on 9 of the 14 factors compared between the two stocks.
About Defiance Daily Target 2X Long LMND ETF
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Defiance Daily Target 2X Long LMND ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long LMND ETF and related companies with MarketBeat.com's FREE daily email newsletter.
